1. Age-related dynamics of lower limb spasticity treatment with abobotulinumtoxinA in patients with cerebral palsy at GMFCS IV-V levels. (January 2021) Authors: Klochkova, Olga; Kurenkov, Alexey; Bursagova, Bella; Ashrafova, Ulvija; Kuzenkova, Lydmila Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Botulinum toxin type A (incobotulinumtoxinA) in cerebral palsy: Combined treatment of spasticity and sialorrhea. (January 2021) Authors: Kurenkov, Alexey; Klochkova, Olga; Kuzenkova, Lydmila; Bursagova, Bella; Ashrafova, Ulvija Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Congenital myopathy as a new phenotype caused by two undescribed variants in ASCC1 gene. Issue 10 (15th July 2022) Authors: Sharova, Margarita; Guseva, Darya; Kurenkov, Alexey; Novoselova, Olga; Murtazina, Aysylu; Skoblov, Mikhail Journal: American journal of medical genetics Issue: Volume 188:Issue 10(2022) Page Start: 3100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Does onabotulinumtoxinA have any central effects in chronic migraine?. (December 2018) Authors: Shevchenko, Vladlena; Artemenko, Ada; Bzhiljanski, Mikhail; Bushkov, Fedor; Kurenkov, Alexey Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. GP126 Large deletions in DMD gene is the most prevalence mutation in russian children with duchenne muscular dystrophy. (June 2019) Authors: Savostyanov, Kirill; Pushkov, Alexander; Kuzenkova, Ludmila; Zhurkova, Natalya; Nikitin, Alexey; Kurenkov, Alexey; Bursagova, Bella; Trufanov, Sergey Journal: Archives of disease in childhood Issue: Volume 104:(2019)Supplement 3 Page Start: A81 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OnabotulinumtoxinA changes cortical excitability in chronic migraine patients after preventive treatment: Observational study over 12 months. (January 2021) Authors: Artemenko, Ada; Shevchenko, Vladlena; Kurenkov, Alexey Journal: Toxicon Issue: Volume 190(2021)supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Role of cortical excitability in chronic migraine prevention: A study design for a randomized open-label trial. (25th December 2016) Authors: Shevchenko, Vladlena; Artemenko, Ada; Tsivileva, Victoria; Tatarinova, Karina; Yahno, Nikolay; Kurenkov, Alexey Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The maximum total dosage of abobotulinumtoxinA for multilevel injections in patients with cerebral palsy, gmfcs levels IV-V. (December 2018) Authors: Kurenkov, Alexey; Klochkova, Olga; Bursagova, Bella; Karimova, Khadizhat; Kuzenkova, Lydmila; Mamedyarov, Ayaz; Kuznetsova, Margarita Journal: Toxicon Issue: Volume 156(2018)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗